Michael Halank

10.5k citations
183 papers · 7.7k · 4 hit papers · h-index 44

Impact in

    • Pulmonary Hypertension Research and Treatments
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Cardiovascular Issues in Pregnancy
    • Cardiovascular Function and Risk Factors
    • Heart Failure Treatment and Management

Papers in

    • Pulmonary Hypertension Research and Treatments 137
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 16
    • Chronic Obstructive Pulmonary Disease (COPD) Research 14
    • Heart Failure Treatment and Management 17
    • Cardiovascular Issues in Pregnancy 16
    • Cardiovascular Function and Risk Factors 10

Michael Halank

167 papers receiving 7.4k citations

Michael Halank's Hit Papers

Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study 2022 · 123 citations
1230+6+13Years since publication100200300400500

Peers

Michael Halank
Comparison fields: 5 of 120
  • Pulmonary and Respiratory Medicine 6.3k
  • Cardiology and Cardiovascular Medicine 3.2k
  • Internal Medicine 403
  • Hepatology 742
  • Genetics 615
Replace Norifumi Nakanishi with:
Norifumi Nakanishi Japan
Roberto Badagliacca Italy
Theresa A. McDonagh United Kingdom
Frances S. de Man Netherlands
Henning J. Gall Germany
Marcin Kurzyna Poland
Stephen C. Mathai United States
James R. Klinger United States
Fumio Sakamaki Japan
Kelly Chin United States
Michael Halank relative to Norifumi Nakanishi Japan Norifumi Nakanishi's profile →
Citations per field
00.5×2×3×4.4×
Norifumi Nakanishi · 1×
Citations per year

Countries citing papers authored by Michael Halank

Since Specialization
Citations

This map shows the geographic impact of Michael Halank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Halank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Halank more than expected).

Fields of papers citing papers by Michael Halank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Halank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Halank. The network helps show where Michael Halank may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Halank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Halank Line = papers co-authored together Michael Halank links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension
Hit paper breakdown →
2006530
2 2006468
3
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry
Hit paper breakdown →
2012365
4 2001317
5 2013291
6 2006239
7
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
Hit paper breakdown →
2021223
8 2010193
9 2015193
10 2013189
11 2012189
12 2005162
13 2020156
14 2018141
15 2007140
16 2011138
17 2005138
18 2022127
19
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study
Hit paper breakdown →
2022123
20 2012119

About Michael Halank

Michael Halank is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Internal Medicine, Hepatology and Critical Care and Intensive Care Medicine, having authored 183 papers that have together received 7.7k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (137 papers), Heart Failure Treatment and Management (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Cardiovascular Issues in Pregnancy (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Cardiovascular Function and Risk Factors (10 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Liver Disease and Transplantation (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.3k citations), Cardiology and Cardiovascular Medicine (3.2k citations), Internal Medicine (403 citations), Hepatology (742 citations) and Genetics (615 citations). Michael Halank has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Marius M. Hoeper, Ralf Ewert, Ekkehard Grünig, Heinrike Wilkens, Christian F. Opitz, Gert Hoeffken, Hossein Ardeschir Ghofrani, Hans-Juergen Seyfarth, Nicola Ehlken and Roland Wensel. Their work appears in journals such as European Respiratory Journal, International Journal of Cardiology, Pulmonary Circulation, Circulation and Lung.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact